Haleon

HLNHealthcare
409.00GBX
0.79%
Market Cap
36.84B
Volume
12.16M
43% of avg
P/E Ratio
0.21
EPS (TTM)
19.16
Beta
0.2
Day Range
405.90p - 411.40p
52 Week Range
319.84p409.00p417.70p
409.00p

Upcoming Events

28 May 2025
Haleon Annual General Meeting
June 5, 2025
Final dividend payment date
High Impact Event
26 June 2025
Completion of the first tranche of the share buyback programme
15 July 2025
Completion of TSKF acquisition
High Impact Event
July 31, 2025
HY 2025 Results
High Impact Event
05 August 2025
H1 2025 Results
High Impact Event
Q4 2025
Q4 2025 Trading Update
High Impact Event
October 30, 2025
Q3 2025 Trading Statement
High Impact Event
HLN
NEUTRAL

Haleon Director Increases Shareholding

The retailer has announced a director has purchased additional shares in the company.

HLN
NEUTRAL

Haleon Announces Director/PDMR Shareholding

The healthcare company has announced changes to its director and PDMR shareholdings.

HLN
NEUTRAL

Haleon Director Increases Stake

The independent non-executive director of the healthcare company has purchased additional shares in the business.

HLN
NEUTRAL

Haleon Director Increases Stake

The retailer announces a director has purchased additional shares in the company.

HLN
NEUTRAL

Haleon Unveils 'Win as One' Strategy to Drive Growth and Productivity

The consumer healthcare company outlines its 'Win as One' strategy, targeting 4-6% annual organic revenue growth and high-single digit adjusted operating profit growth.

HLN
NEUTRAL

Haleon Appoints New Independent Non-Executive Director

The consumer healthcare company has appointed a new independent non-executive director with significant experience in the consumer goods and retail sectors.

HLN
NEUTRAL

Haleon Delivers Q1 Trading in Line with Expectations

The consumer healthcare company reports Q1 trading in line with expectations, providing limited details on performance.

HLN
GOOD

Haleon Increases Ownership of China JV to 100%

The healthcare company has agreed to acquire the remaining 12% equity interest in its China joint venture, TSKF, for £0.2 billion, consolidating its position in the growing Chinese OTC market.

HLN
NEUTRAL

Haleon Directors Increase Shareholdings

The healthcare company Haleon announced that two of its directors, the General Counsel and Chief Marketing Officer, have acquired additional shares in the company through its employee share plan.

HLN
NEUTRAL

Haleon Announces Annual General Meeting Details

The consumer healthcare company Haleon has announced details for its upcoming Annual General Meeting, including the date, time, and availability of meeting documents.